Anthony M Villano1,2, Alexander Zeymo1,3, James McDermott1, Andrew Crocker1, Jay Zeck4, Kitty S Chan1,3, Nawar Shara5,6, Sunnie Kim7, Waddah B Al-Refaie8,9,10,11. 1. MedStar-Georgetown Surgical Outcomes Research Center, Washington, DC, USA. 2. Department of Surgery, MedStar-Georgetown University Hospital, Washington, DC, USA. 3. MedStar Health Research Institute, Hyattsville, MD, USA. 4. Department of Pathology, MedStar-Georgetown University Hospital, Washington, DC, USA. 5. Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University, Washington, DC, USA. 6. Georgetown-Howard Universities Center for Clinical and Translational Science, Washington, DC, USA. 7. Department of Hematology-Oncology, MedStar-Georgetown University Hospital, Washington, DC, USA. 8. MedStar-Georgetown Surgical Outcomes Research Center, Washington, DC, USA. Waddah.B.Al-Refaie@gunet.georgetown.edu. 9. Department of Surgery, MedStar-Georgetown University Hospital, Washington, DC, USA. Waddah.B.Al-Refaie@gunet.georgetown.edu. 10. MedStar Health Research Institute, Hyattsville, MD, USA. Waddah.B.Al-Refaie@gunet.georgetown.edu. 11. Department of Surgery, MedStar Georgetown University Hospital and Georgetown Lombardi Comprehensive Cancer Center, 3800 Reservoir Rd., NW, PHC Building, 4th Floor, Washington, DC, 20007, USA. Waddah.B.Al-Refaie@gunet.georgetown.edu.
Abstract
BACKGROUND: Adequate lymphadenectomy (AL) of 15+ lymph nodes comprises an important component of gastric cancer surgical therapy. Despite endorsement by the National Comprehensive Cancer Network and the Committee on Cancer, initial adoption of this paradigm has been relatively slow. The current analysis sought to perform an adjusted time-trend evaluation of the factors associated with AL and its dissemination. METHODS: Utilizing the 2004-2015 National Cancer Database, 28,985 patients were identified who underwent gastrectomy for adenocarcinoma. An adjusted time-trend analysis was performed to estimate the adoption of AL overall. Multivariable logistic regression was utilized to assess factors associated with these observed trends. Interactions and stratified models determined disparate effects in vulnerable populations (older adults, ethnic minorities, low socioeconomic status). RESULTS: The adjusted time-trend analysis demonstrated an overall 30% increase (28.8 to 58.7%) in receipt of AL (OR 1.10 increase/year; 95%CI 1.09-1.10) from 2004 to 2015. This trend persisted even after stratifying the models by age, race/ethnicity, and income (OR 1.07-1.12; p < 0.05). Slowest rates of adoption were seen amongst hospitals in the Midwest census region (OR 1.08, CI 1.06-1.90) and comprehensive community hospitals (OR 1.08, CI 1.06-1.91) and with African-American patients (OR 1.09, CI 1.06-1.11) (all p < 0.05). CONCLUSION: This multi-center evaluation demonstrates increased adoption of AL during gastric cancer surgery in the USA overall and amongst vulnerable populations, although regional and racial disparities were observed. Future studies are needed to investigate reasons underlying racial and regional differences in receipt of AL.
BACKGROUND: Adequate lymphadenectomy (AL) of 15+ lymph nodes comprises an important component of gastric cancer surgical therapy. Despite endorsement by the National Comprehensive Cancer Network and the Committee on Cancer, initial adoption of this paradigm has been relatively slow. The current analysis sought to perform an adjusted time-trend evaluation of the factors associated with AL and its dissemination. METHODS: Utilizing the 2004-2015 National Cancer Database, 28,985 patients were identified who underwent gastrectomy for adenocarcinoma. An adjusted time-trend analysis was performed to estimate the adoption of AL overall. Multivariable logistic regression was utilized to assess factors associated with these observed trends. Interactions and stratified models determined disparate effects in vulnerable populations (older adults, ethnic minorities, low socioeconomic status). RESULTS: The adjusted time-trend analysis demonstrated an overall 30% increase (28.8 to 58.7%) in receipt of AL (OR 1.10 increase/year; 95%CI 1.09-1.10) from 2004 to 2015. This trend persisted even after stratifying the models by age, race/ethnicity, and income (OR 1.07-1.12; p < 0.05). Slowest rates of adoption were seen amongst hospitals in the Midwest census region (OR 1.08, CI 1.06-1.90) and comprehensive community hospitals (OR 1.08, CI 1.06-1.91) and with African-American patients (OR 1.09, CI 1.06-1.11) (all p < 0.05). CONCLUSION: This multi-center evaluation demonstrates increased adoption of AL during gastric cancer surgery in the USA overall and amongst vulnerable populations, although regional and racial disparities were observed. Future studies are needed to investigate reasons underlying racial and regional differences in receipt of AL.
Authors: Vikas Dudeja; Greer Gay; Elizabeth B Habermann; Todd M Tuttle; Jennifer F Tseng; Barry W Feig; Waddah B Al-Refaie Journal: Ann Surg Oncol Date: 2011-08-12 Impact factor: 5.344
Authors: William F Anderson; M Constanza Camargo; Joseph F Fraumeni; Pelayo Correa; Philip S Rosenberg; Charles S Rabkin Journal: JAMA Date: 2010-05-05 Impact factor: 56.272
Authors: J J Bonenkamp; I Songun; J Hermans; M Sasako; K Welvaart; J T Plukker; P van Elk; H Obertop; D J Gouma; C W Taat Journal: Lancet Date: 1995-03-25 Impact factor: 79.321
Authors: Giuseppe Verlato; Simone Giacopuzzi; Maria Bencivenga; Paolo Morgagni; Giovanni De Manzoni Journal: World J Gastroenterol Date: 2014-09-28 Impact factor: 5.742
Authors: Waddah B Al-Refaie; Greer Gay; Beth A Virnig; Jennifer F Tseng; Andrew Stewart; Selwyn M Vickers; Todd M Tuttle; Barry W Feig Journal: Cancer Date: 2010-01-15 Impact factor: 6.860
Authors: Donna Marie L Alvino; David C Chang; Joel T Adler; Abraham Noorbakhsh; Ginger Jin; John T Mullen Journal: Ann Surg Date: 2017-06 Impact factor: 12.969
Authors: Karl Y Bilimoria; Mark S Talamonti; Jeffrey D Wayne; James S Tomlinson; Andrew K Stewart; David P Winchester; Clifford Y Ko; David J Bentrem Journal: Arch Surg Date: 2008-07
Authors: M Degiuli; M Sasako; A Ponti; A Vendrame; M Tomatis; C Mazza; A Borasi; L Capussotti; G Fronda; M Morino Journal: Br J Surg Date: 2014-01 Impact factor: 6.939